brain radiation and possible presentation of multiple sclerosis

Clicks: 202
ID: 248376
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #87 of 133 articles by views in 2017 ieee international conference on communication, networks and satellite, comnetsat 2017 - proceedings

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 133 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Radiation therapies are commonly used for malignant or metastatic brain tumors for curative and palliative use. The radiation-induced neurotoxicity includes both parenchymal and vascular damage. Here we report the case of a 43-year-old woman who developed Multiple sclerosis (MS) 9 months after she underwent the last session of radiotherapy for the diagnosed meningioma. Conventional doses of radiation might trigger MS.
Reference Key
shaygannejad2013journalbrain Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Vahid Shaygannejad;Mohammad Zare;Helia Maghzi;Parisa Emami
Journal 2017 ieee international conference on communication, networks and satellite, comnetsat 2017 - proceedings
Year 2013
DOI
DOI not found
URL
http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=13;spage=93;epage=95;aulast=Shaygannejad
Keywords
multiple sclerosis meningioma radiation therapymedicine

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.